![](/img/cover-not-exists.png)
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin–cyclophosphamide versus carboplatin–cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study
David S. Alberts, Steve Dahlberg, Stephanie J. Green, Dava Garcia, Edward V. Hannigan, Robert O'toole, Donna Stock-Novack, Earl A. Surwit, Vinay K. Malviya, Christopher J. JollesVolume:
71
Year:
1993
Language:
english
Pages:
10
DOI:
10.1002/cncr.2820710220
File:
PDF, 888 KB
english, 1993